The Texas Collaborative Center for Hepatocellular Cancer (TeCH) at Baylor College of Medicine will host its third annual symposium on September 17, 2022, under the leadership of Dr. Hashem El-Serag. The event will feature several local and national speakers as well as a keynote address by Dr. John Ward, director of the Task Force for Global Health’s Coalition for Global Hepatitis Elimination.
The goal of the symposium is to discuss and chart a path on how to move from science to policy and programs to eliminate hepatocellular carcinoma (HCC), the most common type of primary liver cancer.
With one of the highest rates of end-stage liver disease and liver cancer in the country, Texas is uniquely impacted by this highly lethal disease.
The symposium will combine presentations on the gaps and opportunities for preventing HCC in Texas with a multi-stakeholder conference that will bring together elected officials and decision-makers, community groups, leaders of health care organizations, professional societies, and insurance and industry representatives. Stakeholders across the care continuum will consider how to best bridge the gaps in prevention and treatment of HCC in Texas, with a focus on driving advocacy efforts for policies aimed at statewide elimination of liver cancer/HCC and its underlying risk factors: hepatitis C and B, alcoholic liver disease and fatty liver disease.
This event is co-sponsored by the Baker Institute Center for Health and Biosciences and the Texas Collaborative Center for Hepatocellular Cancer (TeCH) at Baylor College of Medicine (funded by the Cancer Prevention and Research Institute of Texas).
Follow @BakerCHB on Twitter, and join the conversation online with #BakerHealth.
Registration
This is a private event open and free to special guests through the link in their email invitation. Please register using the emailed link, or contact Ariel Harrison at ariel.harrison@bcm.edu. Guests may attend either in person or virtually via Zoom.
Events and webinars are powered by the contributions of our donors and members. Please consider supporting our work by making a gift or joining a membership group. Learn more here or text BAKER to 243725 to give today.
Agenda
|
8:00 a.m. |
|
|
Session I: Overview of the Liver Cancer Epidemic
|
|
8:40 a.m. |
|
|
Session II: Advances in Risk Assessment and Prevention
|
|
9:40 a.m. |
|
|
Discussion
|
|
10:00 a.m. |
|
|
Coffee Break
|
|
10:20 a.m |
Session III: Advances in Detection, Diagnosis and Treatment of Liver Cancer
|
||
| 11:20 a.m. |
Discussion
|
||
| 11:40 a.m. |
Keynote Address and Lunch
|
||
| 12:20 p.m. |
Session IV: Implementing Change
|
||
| 1:00 p.m. |
Multi-stakeholder Conference
|
||
| 2:30 p.m. |
Adjourn
|